TITLE

Molecular Biology of Breast Tumor Progression: A View From the Other Side

AUTHOR(S)
Schnitt, Stuart J.
PUB. DATE
June 2010
SOURCE
International Journal of Surgical Pathology;Jun2010 Supplement 3, Vol. 18 Issue S2, p170S
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the molecular biological aspects of breast tumor progression. It stresses that advances in molecular genetics and biology have offered significant informations on tumor progression. It mentions the significant roles of the tumor microenvironment process in the prognosis of the disease. It further discusses the roles of stromal-epithelial and myoepithelial cells interactions.
ACCESSION #
50882105

 

Related Articles

  • Lobular Neoplasia: Evolution of Its Significance and Morphologic Spectrum. Tavassoli, Fattaneh A. // International Journal of Surgical Pathology;Jun2010 Supplement 3, Vol. 18 Issue S2, p174S 

    The article discusses the significance and morphologic spectrum of lobular intraepithelial neoplasia (LIN). It notes that LIN is characterized by a solid proliferation of small and loosely cohesive cells in the terminal duct-lobular units. It cites the historical, molecular and management of...

  • Will Molecular Classification Replace Traditional Breast Pathology? Schnitt, Stuart J. // International Journal of Surgical Pathology;Jun2010 Supplement 3, Vol. 18 Issue S2, p162S 

    The article discusses the significance of molecular classification in traditional breast pathology. It stresses that various clinical and pathologic factors including axillary lymph nodes status, tumor size, and hormone receptor status are used to classify patients with breast cancer to assess...

  • Morphological profile and receptor status in breast carcinoma: An institutional study. Rao, Chandrika; Shetty, Jayaprakash; HL, Kishan Prasad // Journal of Cancer Research & Therapeutics;Jan-Mar2013, Vol. 9 Issue 1, p44 

    Context: The data on histological and receptor status in breast cancer in an Indian population is limited as receptor status is not routinely carried out for these patients. In the present study, receptor status was analyzed and it was correlated with morphological prognostic parameters....

  • Mutant p53 drives multinucleation and invasion through a process that is suppressed by ANKRD11. Noll, J E; Jeffery, J; Al-Ejeh, F; Kumar, R; Khanna, K K; Callen, D F; Neilsen, P M // Oncogene;6/7/2012, Vol. 31 Issue 23, p2836 

    Mutations of p53 in cancer can result in a gain of function associated with tumour progression and metastasis. We show that inducible expression of several p53 'hotspot' mutants promote a range of centrosome abnormalities, including centrosome amplification, increased centrosome size and loss of...

  • Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer. Fangyong Lei; Longjuan Zhang; Xinghua Li; Xi Lin; Shu Wu; Fengyan Li; Junling Liu // BMC Cancer;2014, Vol. 14 Issue 1, p50 

    Background Prostate tumor overexpressed 1 (PTOV1) was demonstrated to play an important role in cancer progression and was correlated with unfavorable clinical outcome. However, the clinical role of PTOV1 in cancer remains largely unknown. This study aimed to investigate the expression and...

  • Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer. Aggarwal, Anshu; Al-Rohil, Rami N.; Batra, Anupam; Feustel, Paul J.; Jones, David M.; DiPersio, C. Michael // BMC Cancer;2014, Vol. 14 Issue 1, p89 

    Background Expression of integrin α3β1 is associated with tumor progression, metastasis, and poor prognosis in several cancers, including breast cancer. Moreover, preclinical studies have revealed important pro-tumorigenic and pro-metastatic functions for this integrin, including tumor...

  • Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study. Purdie, C A; Quinlan, P; Jordan, L B; Ashfield, A; Ogston, S; Dewar, J A; Thompson, A M // British Journal of Cancer;2/4/2014, Vol. 110 Issue 3, p565 

    Background:Progesterone receptor (PR) expression assessment in early invasive breast cancer remains controversial. This study sought to re-evaluate PR expression as a potential therapeutic guide in early breast cancer; particularly in oestrogen receptor (ER)-positive, lymph node (LN)-negative...

  • Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis. Yuan, Xun; Zhang, Mingsheng; Wu, Hua; Xu, Hanxiao; Han, Na; Chu, Qian; Yu, Shiying; Chen, Yuan; Wu, Kongming // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Various studies have evaluated the significance of Notch1 expression in breast cancer, but the results have ever been disputed. By using 21 studies involving 3867 patients, this meta-analysis revealed that the expression of Notch1 was significantly higher in breast cancer than in normal tissues...

  • miR-320a is an independent prognostic biomarker for invasive breast cancer. HAIPING YANG; JUAN YU; LEI WANG; DI DING; LEI ZHANG; CHENGYU CHU; QI CHEN; ZUDE XU; QIANG ZOU; XIUPING LIU // Oncology Letters;2014, Vol. 8 Issue 3, p1043 

    Breast cancer is one of the most common malignancies worldwide and is the second leading cause of cancer-related mortality among females. miRNAs are a class of small noncoding RNAs that are aberrantly expressed in human cancers. Due to their small size and stability, miRNAs have the potential to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics